GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Slc31a1 | decreases activity | EXP | | 6480464 | CTD | Copper Sulfate results in decreased activity of SLC31A1 protein | PMID:20631178 | Slc31a1 | multiple interactions | EXP | | 6480464 | CTD | [Copper Sulfate results in decreased activity of SLC31A1 protein] which results in decreased uptake of Cisplatin; Copper Sulfate inhibits the reaction [SLC31A1 gene mutant form inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK1 protein]]; Copper Sulfate inhibits the reaction [SLC31A1 gene mutant form inhibits the reaction [FGF2 protein results in increased phosphorylation of MAPK3 protein]] | PMID:20631178 PMID:22842628 | Slc31a1 | decreases expression | ISO | SLC31A1 (Homo sapiens) | 6480464 | CTD | [Copper Sulfate results in decreased expression of SP1 mRNA] which results in decreased expression of SLC31A1 mRNA; Copper Sulfate results in decreased expression of SLC31A1 mRNA | PMID:19549813 PMID:22172574 PMID:22914438 | Slc31a1 | multiple interactions | ISO | SLC31A1 (Homo sapiens) | 6480464 | CTD | Copper Sulfate inhibits the reaction [Cisplatin results in increased expression of SLC31A1 mRNA]; Copper Sulfate inhibits the reaction [SLC31A1 protein results in increased import of Cisplatin]; Copper Sulfate inhibits the reaction [SP1 protein binds to SLC31A1 promoter] | PMID:22172574 PMID:24132751 | |
Go Back to source page | Continue to Ontology report |